Skip to Content
Journal: CancersVolume: 13Number: 6096
Article: First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes
  • Authors:
  • David Lang 1,
  • Linda Ritzberger 2 and
  • Michael Gabriel 4,*
  • et al.
Link: https://www.mdpi.com/2072-6694/13/23/6096

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.